ArticleNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2023

A Phase 1b, Open-Label Study to Evaluate the Safety and Tolerability of the Putative Remyelinating Agent, Liothyronine, in Individuals with MS.

Scott D Newsome et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.